The Proportion Cured of Patients with Resected Stage II–III Cutaneous Melanoma in Sweden

SIMPLE SUMMARY: Patients diagnosed with stage II–III cutaneous melanoma (CM) are at high risk of recurrences, but the CM-specific survival ranges from approximately 40–70%. Here, the cure proportions and survival among uncured stage II–III CM patients were estimated. The 1- and 5-year relative survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Eriksson, Hanna, Utjés, Deborah, Olofsson Bagge, Roger, Gillgren, Peter, Isaksson, Karolin, Lapins, Jan, Schultz, Inkeri Leonardsson, Lyth, Johan, Andersson, Therese M.-L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158378/
https://www.ncbi.nlm.nih.gov/pubmed/34070092
http://dx.doi.org/10.3390/cancers13102456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158378/
https://www.ncbi.nlm.nih.gov/pubmed/34070092
http://dx.doi.org/10.3390/cancers13102456

Ejemplares similares